Masks come off: Israel vaunts virus victory after vaccination
Jerusalem - Israelis stepped into the streets without masks on Sunday for the first time in a year, a key milestone as the country vaccinates its way out of a coronavirus nightmare.
“It’s very strange but it’s very nice,” said Eliana Gamulka (26) after getting off a bus near the busy Jerusalem shopping boulevard of Jaffa Street and removing her face covering. “You can’t pretend that you don’t know anyone any more,” she smiled.
With over half the population fully vaccinated in one of the world’s fastest anti-COVID 19 inoculation campaigns, the Health Ministry announced on Thursday that masks would no longer be required in public outdoor spaces.
For Gamulka, a project manager, the good news came at the perfect time: just two weeks before her wedding. It will be ‘very nice to celebrate with everyone, now without masks’, she said.
“The pictures will be great! I’m very relieved. We can start living again.”
The vaccination of close to five million people has sent Israel’s coronavirus caseload tumbling from some 10,000 new infections per day as recently as mid-January, to around 200 cases a day.
That has allowed the reopening of schools, bars, restaurants and indoor gatherings - although masks are still required in indoor public spaces.
And even before Health Minister Yuli Edelstein’s announcement came into effect, punters in the popular bars of Jerusalem’s Mahane Yehuda market were mask-free and smiling on Thursday evening.
Yet on Sunday, office worker Ester Malka said she wasn’t quite ready to let down her guard. “We’re allowed, but I’m still afraid, I got used to (wearing a mask),” she said.
“I feel like it’s part of my life. We’ll see what happens when everyone has taken them off. If it goes well for a couple of months, then I’ll remove mine.”
Israel just months ago had the world’s highest infection rate, a coronavirus outbreak that left 6,300 people dead among 836,000 cases.
But the Jewish state sent its coronavirus caseload tumbling after striking a deal for a vast stock of Pfizer/BioNTech jabs.
In exchange, it agreed to pay above market price and share data it gathers on the recipients, using one of the world's most sophisticated medical data systems. Since December, some 53 per cent of Israel’s 9.3mn people have received both doses of the jab, including around four-fifths of the population aged over 20.